Look at all the people who die taking pharma drugs,literally thousands a year,and 3 cancer patients full of cancer die taking them...and it wasnt a study,just a recored statistic...BTW...arent the shrooms related to the corner store white button mushrooms?....shouldnt we all be dead by now?...i dont have cancer and ill keep eating mu shrooms...i now am eating all kinds in salads....if they were that bad they would shut down all the grocers by now after 3000 years of consumption...no worries here
heres another study thats claims good results from this Agaricus blazei ,ill bet the the cancer patients in the preious post had a batch with some kind of food poisioning involved...if i had cancer tho,i think i would back off on taking them.
Our findings suggest that previous treatment with A. blazei exerts a "hepatoprotective"effect on both liver toxicity and hepatocarcinogenesis process induced by a moderately toxic dose of DEN.
Abstract
The modifying potential of prior administration of an aqueous extract of the mushroom Agaricus blazei Murrill (Agaricaceae) (Ab) on hepatotoxicity induced by different doses of diethylnitrosamine (DEN) in male Wistar rats was evaluated. During 2 weeks, animals of groups G3 (Ab+DEN50), G5 (Ab+DEN100), G7 (Ab+DEN200), and G8 (Ab-treated) were treated with the A. blazei through drinking water. After this period, groups G2 (DEN50), G3 (Ab+DEN50), G4 (DEN100) G5 (Ab+DEN100), G6 (DEN200), and G7 (Ab+DEN200) were given a single i.p. injection of 50, 100 and 200 mg/kg of DEN, respectively, while groups G1 (non-treated) and G8 (Ab-treated) were treated with 0.9% NaCl only. All animals were killed 48 h after DEN or NaCl treatments. The hepatocyte replication rate was estimated by the index of the proliferating cell nuclear antigen (PCNA) positive hepatocytes and the appearance of putative preneoplastic hepatocytes through expression of the enzyme glutathione S-transferase placental form (GST-P). After DEN-treatment, ALT levels, PCNA labeling index, and the number of GST-P positive hepatocytes were lower in rats that received A. blazei treatment and were exposed to 100 mg/kg of DEN. Our findings suggest that previous treatment with A. blazei exerts a hepatoprotective effect on both liver toxicity and hepatocarcinogenesis process induced by a moderately toxic dose of DEN.
Hey Rocker,
Man, I see your point, and on its face it seems like a reasonable warning. The problem that I see is this is not a study, it's three case histories. As they say, agaricus is commonly used in Japan by cancer patients. The fact that they only have come up with three suspect cases makes me wonder.
I've taken a lot of both agaricus and cordyceps while having my labs done, and I did not experience deleterious effects from either. I guess my question is, if you need rigorous studies to establish efficacy, shouldn't you also need them to establish harmful effects? I've seen that double standard pretty often in medical science.
That being said, I don't take mushrooms now, but only because I think there are more effective things to take, not because I'm worried about them.
YIKS! Thanks to you both. I'll check it out!
There is lots of studies proving this shroom helps liver function tho,looks like the cancer and other things were proberly the cause of this.
http://www.ncbi.nlm.nih.gov/pubmed/17105737